Quotes 5-day view Delayed Nyse
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
109(c)
108.58(c)
106.42(c)
105(c)
105.11(c)
Last
7 297 958
4 518 049
7 104 939
4 237 622
4 404 521
Volume
+1.12% -0.39% -1.99% -1.33% +0.10% Change
Sales 2020
33 885 M - -
Net income 2020
4 415 M - -
Net Debt 2020
11 438 M - -
P/E ratio 2020
42,9x
Yield 2020
1,38%
Sales 2021
38 360 M - -
Net income 2021
5 807 M - -
Net Debt 2021
8 390 M - -
P/E ratio 2021
33,4x
Yield 2021
1,51%
Capitalization
186 B 186 B -
EV / Sales 2020
5,82x
EV / Sales 2021
5,07x
Nbr of Employees
107 000
Free-Float
88,8%
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the...
Notations Surperformance© of Abbott Laboratories
Trading Rating : Investor Rating :
All news about ABBOTT LABORATORIES
News in other languages on ABBOTT LABORATORIES
10/26 AVIS D'ANALYSTES DU JOUR : Adidas, Chargeurs, Daimler, EDF, Ipsen, L'Oréal, SAP,..10/26 Seconde vague 10/23 Les résultats et les couvre-feux se ramassent à la pelle 10/23 EN DIRECT DES MARCHES : Air Liquide, Renault, Accor, Faurecia, Kering, Airbus, I..10/22 ABBOTT : bien orienté avec des propos de broker
Analyst Recommendations on ABBOTT LABORATORIES
United to give travelers free COVID-19 tests on select Newark-London flights
Chart ABBOTT LABORATORIES
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ABBOTT LABORATORIES
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
23
Average target price
117,78 $
Last Close Price
105,11 $
Spread / Highest target
23,7%
Spread / Average Target
12,1%
Spread / Lowest Target
-22,0%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
